Oruka Therapeutics, Inc. (ORKA)
Market Closed
16 Oct, 08:00 PM
$
71. 93
-1.94
-2.6262%
$
4.95B Market Cap
- P/E Ratio
6.45% Div Yield
1.39M Volume
- Eps
$ 73.87
Previous Close 
Want to track ORKA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Oruka Therapeutics, Inc. (ORKA) Statistics
Valuation metrics
Market Cap 4.95B
Enterprise value 4.69B
Trailing P/E (ttm) -33.24
Forward P/E -
PEG ratio -0.61
Price/Sales (ttm) -
Price/Book (mrq) 4.63
Enterprise Value/Revenue -
Enterprise Value/EBITDA -33.08
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.21M
Average volume (90 days) 823K
Price summary
52-Week low 25.11
52-Week high 115.52
Beta -
50-Day moving average 87.16
200-Day moving average 67.8
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 28 Aug 2024
Ex-Dividend Date 29 Aug 2024
Last split factor 1:12
Last split Date 3 Sep 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.12%
Return on equity -0.21%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.11
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 13.89
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 38.51%
Book value per share (mrq) 17.73
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
